Qube Research & Technologies Ltd - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 199 filers reported holding TRANSMEDICS GROUP INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$4,623,638
-14.5%
84,450
+31.2%
0.01%
-40.0%
Q2 2023$5,405,709
+14.0%
64,369
+2.8%
0.02%0.0%
Q1 2023$4,743,879
+581.6%
62,642
+455.5%
0.02%
+400.0%
Q4 2022$695,955
-59.4%
11,276
-72.6%
0.00%
-60.0%
Q3 2022$1,716,00041,1020.01%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q4 2022
NameSharesValueWeighting ↓
Sandhill Capital Partners LLC 1,805,518$34,594,0002.69%
Millrace Asset Group, Inc. 83,723$1,604,0000.94%
Bullseye Asset Management LLC 117,031$2,218,0000.88%
Taylor Wealth Management Partners 72,782$1,395,0000.49%
MOODY ALDRICH PARTNERS LLC 166,078$3,182,0000.44%
HARBOURVEST PARTNERS LLC 116,123$2,225,0000.28%
NEXT CENTURY GROWTH INVESTORS LLC 161,819$3,100,0000.28%
EMERALD MUTUAL FUND ADVISERS TRUST 300,492$5,757,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 82,255$1,576,0000.18%
EMERALD ADVISERS, LLC 244,816$4,691,0000.17%
View complete list of TRANSMEDICS GROUP INC shareholders